Literature DB >> 18236118

Early hepatocellular carcinoma: pathology, imaging, and therapy.

Tadatoshi Takayama1, Masatoshi Makuuchi, Masamichi Kojiro, Gregory Y Lauwers, Reid B Adams, Stephanie R Wilson, Hyun-Jung Jang, Chusilp Charnsangavej, Bachir Taouli.   

Abstract

BACKGROUND: In 1987, Japanese researchers proposed to define the pathological concept of early hepatocellular carcinoma (HCC). However, there are some conceptual differences between the East and the West in the diagnosis and treatment of early HCC.
METHODS: To provide up-to-date data for making a worldwide consensus, this article has collected six papers focused on the management of early HCC, which were presented in the Fifth International Meeting of "Hepatocellular Carcinoma: Eastern and Western Experiences" in Houston in January 2007.
RESULTS: In the pathological perspective, the common criteria to discriminate early HCC from dysplastic nodule included hepatocytic invasion of portal triads and septa (stromal invasion). The current imaging modalities such as contrast-enhanced ultrasound (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI) with the use of intravenous contrast material with multiphasic imaging could enhance their ability to accurately characterize early HCC. From the treatment perspective, a single early HCC had a high chance for cure by resection, ablation, or transplantation, which proved to be the earliest clinical entity (Stage 0 HCC).
CONCLUSIONS: Early HCC is characterized by its incipient malignant nature and by an extremely favorable clinical outcome, thereby justifying its definition.

Entities:  

Mesh:

Year:  2008        PMID: 18236118     DOI: 10.1245/s10434-007-9685-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

1.  Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma.

Authors:  Vincent Vandecaveye; Frederik De Keyzer; Chris Verslype; Katya Op de Beeck; Mina Komuta; Baki Topal; Ilse Roebben; Didier Bielen; Tania Roskams; Frederik Nevens; Steven Dymarkowski
Journal:  Eur Radiol       Date:  2009-05-14       Impact factor: 5.315

2.  Evaluation of Podoplanin Expression in Hepatocellular Carcinoma Using RNAscope and Immunohistochemistry - A Preliminary Report.

Authors:  Andreea Cioca; Anca Maria Cimpean; Raluca Amalia Ceausu; Valeria Tarlui; Alina Toma; Irina Marin; Marius Raica
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

Review 3.  Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging.

Authors:  Jens Ricke; Max Seidensticker; Konrad Mohnike
Journal:  Liver Cancer       Date:  2012-06       Impact factor: 11.740

Review 4.  Recent advances in multidisciplinary management of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Imam Waked
Journal:  World J Hepatol       Date:  2015-04-08

5.  Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma.

Authors:  Jong Man Kim; Choon Hyuck; David Kwon; Jae-Won Joh; Joon Hyeok Lee; Seung Woon Paik; Cheol Keun Park
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

6.  No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma.

Authors:  Yutaka Midorikawa; Tadatoshi Takayama; Satoshi Nara; Takuya Hashimoto; Kiyohiko Omichi; Kiyoko Ebisawa; Tokio Higaki; Shingo Tsuji; Hirohiko Sakamoto; Kazuaki Shimada; Masatoshi Makuuchi
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

7.  The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Yusuke Kawamura; Masafumi Inoue; Masaji Hashimoto; Kenji Ikeda; Hiromitsu Kumada; Goro Watanabe
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

Review 8.  Biomarkers for the early diagnosis of hepatocellular carcinoma.

Authors:  Nobuhiro Tsuchiya; Yu Sawada; Itaru Endo; Keigo Saito; Yasushi Uemura; Tetsuya Nakatsura
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

9.  Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.

Authors:  Hyungjin Rhee; Ji Hae Nahm; Haeryoung Kim; Gi Hong Choi; Jeong Eun Yoo; Hye Sun Lee; Myoung Ju Koh; Young Nyun Park
Journal:  Mod Pathol       Date:  2016-06-17       Impact factor: 7.842

Review 10.  Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment.

Authors:  Mengtao Xing; Xinzhi Wang; Robert A Kiken; Ling He; Jian-Ying Zhang
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.